Logo image of GENX.CA

GENIX PHARMACEUTICALS CORP (GENX.CA) Stock Analyst Earnings Estimates

TSX-V:GENX - TSX Venture Exchange - CA37232A1093 - Common Stock - Currency: CAD

0.035  +0.01 (+16.67%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024
Revenue
YoY % growth
GENX.CA revenue by date.GENX.CA revenue by date.
12.4K4.1K
-66.94%
EBITDA
YoY % growth
GENX.CA ebitda by date.GENX.CA ebitda by date.
-468.4K
58.17%		-334.8K
28.52%		-241.1K
27.99%
EBIT
YoY % growth
GENX.CA ebit by date.GENX.CA ebit by date.
-1.033M
37.66%		-882.2K
14.57%		-242.2K
72.55%
Operating Margin
GENX.CA operating margin by date.GENX.CA operating margin by date.
N/A-7,114.52%-5,907.32%
EPS
YoY % growth
GENX.CA eps by date.GENX.CA eps by date.
N/AN/AN/A

All data in CAD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CAD

Recent Earnings VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (CAD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth		 1K
-62.96%		%
Q2 2024
Q2Q % growth		 2.9K
-64.20%		%
Q1 2024
Q2Q % growth		 100
-93.75%		%
Q4 2020
Q2Q % growth
-100.00%		%
Q2 2020
Q2Q % growth
-100.00%		%
Q1 2020
Q2Q % growth
-100.00%		%
GENX.CA Yearly Revenue VS EstimatesGENX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2023 2024 200K 400K 600K 800K
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A N/A N/A
RevenueN/A N/A N/A N/A